Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not a lie at all. They did the animal studies which concluded with the animal toxicology results under the CRADA. This work was completed by Dr. Emily Chew who is with the NEI. The human trials will also be conducted under the CRADA. If you choose to believe otherwise that is your choice and does not alter the fact they are well into the CRADA. More of a reason for you to sell. I will buy all your shares (I believe you said it was 250K shares) for .013. Just let me know and we can work it out.
They got the CRADA with the NEI which was completed with toxicology results by Dr. Emily Chew, a world renowned eye doctor and researcher. That one fact nullifies your wild and irresponsible claims of fraud and not accomplishing anything they said they were trying to do. Doing what they are trying to do is not an easy proposition. I believe people will be rewarded in time. If you feel they have committed fraud why do you own shares? It seems illogical to me.
Got my orders in. Hopefully they trigger. They are good to cancel so they will need to sell me shares if they want to go low, which I will take. These levels are appealing to me. Last time had a few buys at .017.
That’s a nice position. Hopefully we can get some financing here soon. I am hoping for something private and not a public offering with no reverse split. Would like to see IND before reverse split. Always hated they went with Aegis. We shall see. Funny to me how some people here don’t believe your holdings. LOL. I am not far behind you in share count.
The uplist strategy, whatever that is, will not happen any time soon according to Ken. He pretty much said as much on the call when he said the Nasdaq is not in the near term. Beyond that Ken has stated that they will not reverse split prior to .05. He needs to stay true to his word on that.
On another note, I am glad to see what Huntpost is doing. I think they have big upside. However I go back to the Q4 podcast when he intimated a liquidity event was imminent. Based on yesterday’s podcast it sounds like they are working on LOI’s for 20 trade show companies. There is still a lot of work to do here. Why intimate they were close to a liquidity even in Q4 when it appears now they are still a ways off. I personally am disappointed by the messaging that took place in 2022 and Q4 in particular on the Huntpost liquidity event.
I am still long but always look at things with a critical eye. Still hopeful for positive news moving forward.
This was an email I received from the company 40 minutes ago. Perhaps it is old news. Thought I would send along. Sure it will be discussed on the podcast. Thanks.
MjLink Acquisition Update - February 23rd, 2023
It is official, MjLink has executed a letter of intent to be purchased by a U.S. based company currently operating in the hemp and cannabis industry.
As part of the terms in the LOI, the name of the acquiring cannabis company, and the details of the proposed acquisition, will remain private until the that company makes a public announcement to their shareholders.
In the meantime, both parties are working on the final details that will be added to their Definitive Purchase Agreement.
Please tune in to the shareholder podcast this evening. Use this link to connect and watch...
Should be good valuation. I would like to see the IND drop before the RS and uplist. Maybe with Aegis inability to get the financing done they will secure some short term funding elsewhere. We shall see.
I have a hunch Conix was not being as literal as you are thinking. My interpretation of what he said is that if the stock goes down anywhere near that he’s a buyer. And so am I. In fact, I am a buyer under .02.
Other than the few hundred thousand shares that I have added to my war chest. I’m sure a few other holders here have added at opportune times. And no, I don’t care if you believe me or not. Cheers Rob.
Never ever. Now if they were convicted then that may be a different story. It’s all laughable.
The buy signal has officially appeared. For those here long enough, you know what/who I’m talking about. I’m a buyer on Monday.
A $12.57M market cap here is just ridiculous given the potential of Huntpost alone.
The potential for Huntpost is massive. Been watching a lot of their videos and involvement at the trade show. Love what they are doing. If they can partner with dozens of these trade shows they will become a household name in the outdoor rec. industry. The exposure these mom and pops could get from Huntpost is large. A liquidity event will bring in capital that they could use to really scale their reach. I am most excited about this TBI company.
Just curious why are people limited on their responses?
You obviously know very little about order flow and how Market Makers control it. You should research the topic. What iRobot mentioned has happened to me countless times.
It happens on many stocks. It is market makers controlling order flow. Has happened to me countless times on stocks, not just here. We also don’t see all the orders on Level 2.
It’s called continuing education. Very common for executives to take these types of courses. For some professions it is mandatory. And yes it is completely appropriate to include in a resume. Don’t think he mentioned it to trick anyone. Ive had some criticisms of the company but this entry on a resume is the least of my concerns.
And this may lead to the granting of a PRV which would easily have a $100M value. I have been waiting on progress on other solutions so they are not a one trick pony long term.
They’re an OTC Pink. Come on man. I thought you were leaving.
One question I have is…In a podcast late in 2022 (maybe even December), Ken discussed potential liquidity events for both MJLink and Huntpost. He made it sound like the MJLink acquisition was about to happen and they were literally waiting for documents to be signed by the buyer.
We have heard nothing about this since that call. Makes wonder if that deal has gone south since we have received no update. Again I think Ken should not have positioned it the way he did given the fact that there has been no subsequent update.
I know some may feel like these things take time, there are a lot of moving parts, etc. However, I was left with the feeling it would get done by the end of the year, particularly since Ken had been hinting at liquidity events to happen in 2022 all of last year.
Ken or IR, if you read this, can you please provide an update on this?
Uber the asset is simply a means to an end. Don’t overthink it. It is set up to prequalify companies for their TBI program. Ultimately the company’s success is tied to companies in their TBI program reaching some kind of liquidity event which will allow them to grow their business. WDLF will then own 15% of the company and get 5% of their sales. This is the core of their business strategy. Do this 100 times and you have created a nice incubator company that should create value. The bigger question is not around the value of this asset but rather around when will they actually execute a liquidity event in their TBI program.
Why do you feel they did not do a PR on the original animal studies? They began in early May and should have been completed in mid-August. Seems that would have been a fact-based material, non-promotional event that they could have PR’d to update shareholders. And I think it would have helped the share price. I think they missed an opportunity on this.
When will Ken learn to stop saying things he ends up not doing? This has been a pattern for a long time. He needs to just report news as it happens and stop making promises on communicating that he can’t keep. It is an addiction he needs to break.
I doubt it. Looks like they are pushing it right back to .02 today. If Aegis is involved they will not do retail any favors.
I think they have figured out the formulation.
The animal studies are done. The toxicology test as reported in the PR last week followed the animal studies. They do need to manufacture a small amount of the drug for the human trials that will be administered under the CRADA. This is very typical of the process.
Why don’t you do a little due diligence?
Ah so it was collecting on A/R that drove the revenue increase? Thanks for that clarification. That is better than falling off revenues from the business.
I do think the annual sales increase is great news. Just wondering why Q4 revenues fell so much on a sequential basis from Q3 to Q4 2022. Hopefully that is addressed on the call for the 10K release.
It is a question of market cap. The market cap is the same post split. Lower price more shares pre-split, higher price fewer shares post split. It is a math equation. It is equally challenging to make a run. The right news can make either outcome happen.
If it was $1.5M in Q 4 Ken would have been yelling that from the rooftops.
I heard total company revenues for 2022 well over $900K.
I heard the $900K+ was for the year, not Q4.
Good question. Ken has always talked about liquidity events as it relates to companies in their TBI program being sold or going through an IPO. Perhaps it might make it more appealing for Weedlife to go through their own liquidity event at some point in the future. It is an LOI and I am sure the work that needs to be done to complete a deal will take some time.
Hello ‘“Lakota-45”…
To address your questions….
1) Previously answered. See prior post.
2) No. But have worked for several publicly traded companies which actually had a successful business model. We also had business leaders whose heads were not in the clouds.
Just curious….Is running a publicly traded company a prerequisite to developing opinions on a company’s business model and execution….Just curious….
Happy New Year “Lakota-45”. Let’s hope that Ken can deliver on a liquidity event that has some legs underneath it and drives shareholder value in 2023. The jury remains out for me on his ability to get one done. Hope you’re right and I’m wrong.
This is a pretty arrogant response in my mind. Instead of addressing my concerns you question my experience in the market. Laughable.
To answer your question, about 40 years. Good luck to all, especially LONGS.
One final observation from the podcast. Ken rescheduled the podcast twice for what basically was no new information. Why? I know, because they’re waiting for the name change. Here’s a novel idea. Why not wait for material news to actually happen to file the 8K then do the podcast. That would build more trust with people, at least with me anyway. But no, Ken schedules podcasts to keep hope alive that what he claims will happen will actually happen one day. And if he waited two extra weeks for the podcast to do a PR about a LOI to acquire a CBD company it was a waste of time. Had zero impact on price. What will have a material impact on price is a liquidity event.
Looking forward to the day when Ken has a podcast that actually talks about material news that happened, not his pie in the sky dreamland.
One final note, where is Todd Markey? I know his name was in the PR for the LOI, but his title was Investor Relations. Just an observation since Ken has not so much has mentioned Todd’s name since he disappeared from the podcasts. A little update on Todd’s status would be nice.
Cheers and happy new year to all.
That’s an odd response to my observations about a podcast.
My predictions a couple weeks ago related to the podcast today…
“My predictions for the next couple weeks prior to year end. No name change this week. No PR’s prior to the 12/29 podcast, the final of the year. And there will be few updates we don’t already know on the podcast.” In other words, Ken will kick the can down the road. Hope I am wrong but if I’m a betting man these are my bets.
Just listened to the podcast. My observations.
1. Revenues for Q4 likely $300K based on Ken’s prediction of being well over $900K for the year. I assumed $950K for the year. End of Q3 revenue was $651K YTD. They reported $511K in Q3 so revenue for Q4 on a sequential basis from Q3 was down 41%. Why did revenues decrease so dramatically from Q3 to Q4?
2. Huntpost SPAC now seems tied to the acquisition of several trade shows. They have purchased no trade shows at this point. This won’t happen any time soon in my opinion.
3. As for the MJ Link acquisition, it seems like they are waiting on the buyer and that it is out of their control. Generally I don’t like the sound of this. Ken always seem to indicate that the MJ Link liquidity event was tied to the safe banking act. Well we know that ain’t happening any time soon.
4. Bottom line just as I expected is that he said nothing new we did not already know and he equivocally kicked the can down the road. Everything now is 2023, the same time he said about 2022 at the end of 2021.
For a certain poster on this board, please don’t tell me I’m confused. I have zero confusion on what is happening here. If I have any confusion it is wondering why several longs here refuse to question or hold Ken accountable for not meeting his expectations. He’s been at this for TEN years and still hasn’t hit $1M in annual revenues.
My bold prediction for Q1 2023. NO LIQUIDITY EVENTS WILL HAPPEN.
Hope I’m wrong but I have been right the last several months on this one.